Skip to main content

BBH

ETF
—
—

Performance overview

BBH Price
Price Chart

Forward-looking statistics

Beta
0.54
Risk
17.10%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodPassively Managed
DiversifiedNo
Expense ratio0.35%
Asset classUnknown

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNASDAQ
Type of shareN/A
Earnings per share (EPS)—
Dividend per share$2.50
Revenue per share—
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$1M
Put-call ratioN/A

Macro factor sensitivity

Growth+0.4
Credit+2.8
Liquidity+0.3
Inflation-2.4
Commodities0.0
Interest Rates-1.2

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayDecember 23, 2024

News

Should You Invest in the VanEck Biotech ETF (BBH)?

Launched on 12/20/2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Zacks Investment Research (June 30, 2025)
Should You Invest in the VanEck Biotech ETF (BBH)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.

Zacks Investment Research (April 29, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free